Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
Location: United Kingdom
Total raised: $1.33M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.07.2026 | Pre-Seed | $1.33M | Startup Fu... |
Mentions in press and media 4
| Date | Title | Description |
| 13.07.2026 | Europe's Fusion Future: Proxima Secures Google Backing for Stellarator Power | Proxima Fusion, a German startup, secures a massive $468M funding round, with Google as a strategic investor. The mission: build Europe's first commercial stellarator fusion power plant. This critical investment accelerates the intense glob... |
| 10.07.2026 | Nscale secures $1.4B, Proxima Fusion lands €411M, and Invest Europe sees VC rebound | This week, we tracked more than 70 tech funding deals worth over €2.8 billion and over 5 exits, M&A transactions, rumours, and related news stories across Europe. Alongside the week’s top funding rounds, we’ve highlighted key industry d... |
| 08.07.2026 | Respiro Diagnostics secures £1M to advance lung diagnostics | Respiro Diagnostics, a UK-based startup developing breath-based diagnostics for lung diseases, has raised £1 million in a pre-seed funding round led by Zinc Venture Capital and SFC Capital. The round also included participation from Amadeus... |
| - | Respiro Diagnostics | “Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.” |